SciELO - Scientific Electronic Library Online

 
vol.28 número2Expresión de CDX2 en lesiones de vejiga urinaria y uretraTratamiento de la inestabilidad vesical (vejiga hiperactiva no neurógena) en niños, con tolterodina índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Actas Urológicas Españolas

versión impresa ISSN 0210-4806

Resumen

VEGA VEGA, A. et al. Cellular acute rejection pig to human in an ex vivo renal transplant model. Actas Urol Esp [online]. 2004, vol.28, n.2, pp.106-121. ISSN 0210-4806.

OBJECTIVE: Ex vivo perfusion model of pig-to-human kidney xenotransplantation to evaluate human antiporcine xenograft rejection once hyperacute rejection (HAR) is avoided. METHODS: Pig kidneys were perfused for 3 hours with pig blood (group 1; n=5), human blood (group 2; n=5), complement heat innactivated human blood (group 3; n=5), platelet-depleted human blood (group 4; n=5); and xenoreactive natural antibodies (XNA)-depleted human blood (group 5; n=5). Tissue samples were studied with immunoperoxidase techniques. RESULTS: Pig kidneys perfused with human blood, group 2, showed HAR with interstitial haemorrhage, vascular thrombi and glomerular injury. Pig kidneys perfused with manipulated human blood (groups 3 to 5) had no histologic evidence of HAR, but showed signs of acute cellular rejection with different degrees of interstitial infiltrate of mononuclear cells, specially in the XNA-depleted group. CONCLUSIONS: The model may be valuable in the isolated evaluation of the elements involved in the pig-tohuman xenorejection. The depletion of complement, platelets and XNA protected porcine kidneys form HAR in our study and allowed the development of an acute cellular rejection, a very unusual fact in this short time, 3 hours.

Palabras clave : Xenotransplant; Hyperacute rejection; Acute cellular rejection.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons